Santiago Ávila‐ríos - Infectious Diseases

Author Information

Santiago Ávila-Ríos is a distinguished researcher affiliated with the Centre for Research in Infectious Diseases at the National Institute of Respiratory Diseases in Mexico City, Mexico. His research focuses on infectious diseases, with a particular emphasis on the epidemiological and clinical aspects of viral infections, including HIV and SARS-CoV-2.

Research Contributions

Santiago Ávila-Ríos has made significant contributions to the field of infectious diseases, particularly in understanding the dynamics of viral infections and their impact on public health. In 2022, he co-authored studies on various aspects of SARS-CoV-2, such as seroepidemiology among healthcare personnel, genomic characterization, and immune responses in infected and vaccinated populations. He also investigated the clinical management of people living with HIV during the COVID-19 pandemic and explored the biological markers and implications of the virus in critically ill patients. His work on the HIV-1 reservoir and the respiratory microbiota in COVID-19 patients highlights his breadth of expertise in virology and immunology.

Aliases

Santiago Ávila-Ríos is known by several aliases, including Santiago Avila-rios, Santiago Ávila-ríos, S Avila-rios, and S. Avila-ríos. These variations are often used interchangeably in academic and research publications.

Publication and Citation Metrics

Metric	Value
Total Citation Count	1708
H-Index	23
Total Paper Count	130

Publications:

Role of Urinary Kidney Stress Biomarkers for Early Recognition of Subclinical Acute Kidney Injury in Critically Ill COVID-19 Patients

DOI: 10.3390/biom12020275

Year: 2022

Seroepidemiology of SARS-CoV-2 in healthcare personnel working at the largest tertiary COVID-19 referral hospitals in Mexico City

DOI: 10.1371/journal.pone.0264964

Year: 2022

The Alpha Variant (B.1.1.7) of SARS-CoV-2 Failed to Become Dominant in Mexico

DOI: 10.1128/spectrum.02240-21

Year: 2022

Extensive heterogeneity of the HIV-1 infected CD4+ T-cell reservoir revealed by single-cell viral ASAPseq

DOI: 10.1101/2022.04.02.486753

Year: 2022

POSTERIOR SEGMENT OCULAR FINDINGS IN CRITICALLY ILL PATIENTS WITH COVID-19

DOI: 10.1097/IAE.0000000000003457

Year: 2022

Antibody and memory B-cell immunity in a heterogeneously SARS-CoV-2 infected and vaccinated population

DOI: 10.1101/2022.02.07.22270626

Year: 2022

Genomic Characterization of SARS-CoV-2 Isolated from Patients with Distinct Disease Outcomes in Mexico

DOI: 10.1128/spectrum.01249-21

Year: 2022

Clinical Follow-Up in People Living with HIV During the COVID-19 Pandemic in Mexico

DOI: 10.1007/s10461-022-03626-4

Year: 2022

Role of HMGB1 in Cisplatin-Persistent Lung Adenocarcinoma Cell Lines

DOI: 10.3389/fonc.2021.750677

Year: 2021

Dysbiosis and structural disruption of the respiratory microbiota in COVID-19 patients with severe and fatal outcomes

DOI: 10.1038/s41598-021-00851-0

Year: 2021

What are Apicomplexan Parasites?

How can individuals protect themselves from HIV?

Why are Surveillance Systems Important?

What Types of Pathogens are Commonly Spread by Direct Contact?

How Does Viral Interference Occur?

What are the symptoms of Plasmodium falciparum malaria?

What is a Retrovirus?

How is HFMD Transmitted?

How Effective is Handwashing in Preventing Disease Transmission?

How Do Vectors Transmit Diseases?

Partnered Content Networks

Relevant Topics